Development and Implementation of Tennessee Nonresidential Buprenorphine Treatment Guidelines
Objective: To describe the recent legislation in Tennessee and subsequent development and implementation of state-wide buprenorphine treatment guidelines. Practice Innovation: In 2016, Tennessee began licensing office-based opioid treatment (OBOT) clinics. Due to initial licensing criteria, not all...
Saved in:
Main Authors: | Erica Schlesinger (Author), Wesley Geminn (Author), Kenneth C Hohmeier (Author), Howard L Burley Jr (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review
by: Joanna Risby, et al.
Published: (2023) -
The Tennessee Medicaid medication therapy management program: early stage contextual factors and implementation outcomes
by: Kenneth C. Hohmeier, et al.
Published: (2021) -
Views of the Pharmacists' Role in HPV Vaccinations: A Qualitative Study in Tennessee
by: Alina Cernasev, et al.
Published: (2024) -
Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment
by: Kenneth C. Hohmeier, et al.
Published: (2023) -
Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists
by: Kenneth Charles Hohmeier, et al.
Published: (2023)